California Cannabis Research Medical Group


O'Shaughnessy's Home

This Issue Home







Spring 2004
Journal of the California Cannabis Research Medical Group

More California Doctors Approve Cannabis

Cannabis in the Cirriculum Dr. Jensen's Syllabus

Cannabis Specialists Agree on Health History Questionnaire

Implementation of the Compassionate Use Act in a Family Medical Practice by Frank H. Lucido, MD, with Mariavittoria Mangini, PhD, FNP

Volcano Vaporizer

Clinical Observations:

  • Atrophie Blanche Treated With Cannabis and/or THC by Tod H. Mikuriya, M.D.
  • Three Consecutive Patients in a Therapeutic Cannabis Medical Practice by Philip A. Denney, MD

Center for Medicinal Cannabis Research has 18 State-Funded Studies in the Pipeline by Dale Gieringer List of funded studies

Notes Regarding Patterns of Use by Tom O'Connell, MD

Which Conditions Are Treatable With Cannabis?

"Therapeutic Potential" In Spotlight at Cannabinoid Researchers' Meeting by Fred Gardner

The Legal Status of Medical Marijuana by Alice Mead

Cannabis for the Wounded Editorial

What's in a Name?
At the Spring meeting of the California Cannabis Research Medical Group, Philip A. Denney, MD, questioned whether the name really applied to doctors who are independent practitioners. The appropriateness of "California" was also discussed, since doctors in other states -and countries- are treating and consulting with patients who use cannabis as medicine. And shouldn't the second "C" word be "Cannabinoids?" to include compounds made in the lab and in the body?
Jeff Hergenrather, MD, thinks the CCRMG name works. The member-doctors may have disparate and diverse practices, but they have a common interest in studying the clinical applications of cannabis, i.e., doing research. So it stands, for now. Doctors and others who want to learn more about the CCRMG should contact info<AT> or John Trapp at 510-548-1188.
O'Shaughnessy's seeks to be a forum for doctors, nurses, caregivers and patients who are interested in the clinical applications of cannabis.
The main goal of this issue is to confront and demolish the lie perpetrated by the U.S. Drug Enforcement Association that there have been thousands of studies showing cannabis to be harmful and none showing beneficial medical effect.
Copies or bundles of O'Shaughnessy's are available to physicians for distribution to patients. A sound doctor-patient relationship requires a level of honesty that Prohibition makes very difficult to achieve. Placing O'Shaughnessy's in the waiting room is a good way to "break the ice" and encourage patients to confide about their cannabis use.
To be listed as a supporter, or to get involved as a contributor, a distributor, of on any other level, please contact 510-548-1188 or journal<AT>
Confidentiality respected.
Our mailing address is p.o. box 9143 Berkeley CA 94709.
The paper is online at http//
Subscriptions are $12 for four issues.
Fred Gardner, Managing Editor



O'Shaughnessy's is the journal of the CCRMG/SCC. Our primary goals are the same as the stated goals of any reputable scientific publication: to bring out findings that are accurate, duplicable, and useful to the community at large. But in order to do this, we have to pursue parallel goals such as removing the impediments to clinical research created by Prohibition, and educating our colleagues, co-workers and patients as we educate ourselves about the medical uses of cannabis.
The Society of Cannabis Clinicians (SCC) was formed in the Autumn of 2004 by the member physicians of CCRMG to aid in the promulgation of voluntary standards for clinicians engaged in the recommendation and approval of cannabis under California law (HSC §11362.5).

As the collaborative effort continues to move closer to issueing guidelines, this site serves as a public venue for airing and discussing these guidelines.

Visit the SCC Site for more information.